LifeLabs Genetics is proud to announce the expansion of our molecular diagnostic testing capabilities. As a result of feedback from healthcare providers across the country who want access to Canadian genetic testing options, we are now offering testing for inherited conditions, using next-generation sequencing, from our lab in Surrey, British ...

Tuberous sclerosis complex is a genetic disorder characterized by the growth of numerous benign tumors in vital organs, such as skin, brain, kidneys among others. Common clinical indications of TSC include, but are not limited to: Skin Patches of white- or light-coloured skin (Hypomelanotic macules) Oval-shaped skin lesions (Shagreen ...

Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s Disease, is a late-onset and rapidly-progressing neurodegenerative disease.1 Most cases of ALS appear in individuals with no family history of ALS, referred to as sporadic. The mean age of onset of sporadic ALS is 56 years of age. ...

In March 2019, the Clinical Pharmacogenetics Implementation Consortium (CPIC) published a new guideline concerning CYP2D6 and atomoxetine, a non-stimulant medication used in the treatment of some people with attention-deficit/hyperactivity disorder. Currently, this drug is included in the TreatGx pharmacogenetic report and precision prescribing software, and we provide relevant information to ...